TY - JOUR
T1 - Who enrolls in the medicare part D prescription drug benefit program? Medication use among patients with heart failure
AU - Eapen, Zubin J.
AU - Hammill, Bradley G.
AU - Setoguchi, Soko
AU - Schulman, Kevin A.
AU - Peterson, Eric D.
AU - Hernandez, Adrian F.
AU - Curtis, Lesley H.
N1 - Funding Information:
Damon M. Seils, MA, Duke University, prepared the manuscript, for which he did not receive compensation apart from his employment at the institution where the study was conducted. This work was supported by an award from the American Heart Association Pharmaceutical Roundtable and David and Stevie Spina. Dr Eapen received funding from an American Heart Association Pharmaceutical Roundtable outcomes training grant (0875142N). This project was also supported in part by grant number U19HS021092 from the Agency for Healthcare Research and Quality. The content is solely the responsibility of the authors and does not represent the official views of the Agency for Healthcare Research and Quality.
Publisher Copyright:
© 2013 The Authors.
PY - 2013
Y1 - 2013
N2 - Background--Dispensing data from Medicare Part D standalone prescription drug plans are now available, but characteristics of enrollees with heart failure have not been well described. Methods and Results--We identified 81 874 patients with prevalent heart failure as of January 1, 2010, in a nationally representative 5% sample of Medicare beneficiaries. We classified patients according to enrollment in a Medicare Part D plan as of January 1, 2010. Demographic characteristics, comorbid conditions, and prescriptions were compared by enrollment status. A total of 49 252 (60.2%) were enrolled in a Medicare Part D plan as of January 1. Enrollees were more often women, black, and of lower socioeconomic status. Enrollees with heart failure more often filled prescriptions for loop diuretics than angiotensin-converting enzyme inhibitors or angiotensin receptor blockers, β-blockers, or aldosterone antagonists. During the first 4 months of 2010, 5444 (12.3%) reached the coverage gap, and 566 (1.3%) required catastrophic coverage beyond the gap. Conclusions--Medicare beneficiaries with heart failure differ significantly according to enrollment in Part D prescription drug plans and represent a population underrepresented in clinical efficacy trials. Many face the coverage gap, and few select Medicare Part D plans that provide coverage during the gap. Linking Medicare Part D event data with clinical registries could help to determine whether eligible enrollees are undertreated for heart failure.
AB - Background--Dispensing data from Medicare Part D standalone prescription drug plans are now available, but characteristics of enrollees with heart failure have not been well described. Methods and Results--We identified 81 874 patients with prevalent heart failure as of January 1, 2010, in a nationally representative 5% sample of Medicare beneficiaries. We classified patients according to enrollment in a Medicare Part D plan as of January 1, 2010. Demographic characteristics, comorbid conditions, and prescriptions were compared by enrollment status. A total of 49 252 (60.2%) were enrolled in a Medicare Part D plan as of January 1. Enrollees were more often women, black, and of lower socioeconomic status. Enrollees with heart failure more often filled prescriptions for loop diuretics than angiotensin-converting enzyme inhibitors or angiotensin receptor blockers, β-blockers, or aldosterone antagonists. During the first 4 months of 2010, 5444 (12.3%) reached the coverage gap, and 566 (1.3%) required catastrophic coverage beyond the gap. Conclusions--Medicare beneficiaries with heart failure differ significantly according to enrollment in Part D prescription drug plans and represent a population underrepresented in clinical efficacy trials. Many face the coverage gap, and few select Medicare Part D plans that provide coverage during the gap. Linking Medicare Part D event data with clinical registries could help to determine whether eligible enrollees are undertreated for heart failure.
KW - Heart failure
KW - Medicare Part D
KW - Outcome assessment (health care)
UR - http://www.scopus.com/inward/record.url?scp=84891684757&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84891684757&partnerID=8YFLogxK
U2 - 10.1161/JAHA.113.000242
DO - 10.1161/JAHA.113.000242
M3 - Article
C2 - 24025363
AN - SCOPUS:84891684757
SN - 2047-9980
VL - 2
JO - Journal of the American Heart Association
JF - Journal of the American Heart Association
IS - 5
M1 - e000242
ER -